Ischaemic stroke subtypes and their genetic basis: A comprehensive meta-analysis of small and large vessel stroke

European Neurology

Volumn 61, Issue 2, 2009, Pages 76-86

  Rao, Rohit ^a   Tah, Vikas ^a   Casas, Juan Pablo ^b   Hingorani, Aroon ^c   Whittaker, John ^b   Smeeth, Liam ^b   Sharma, Pankaj ^a,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Genetics, stroke; Lacunae stroke; Large vessel disease; Meta analysis; Polymorphism; Small vessel disease; Stroke subtype

Indexed keywords

BASE; DAPSONE;

ARTICLE; BLOOD VESSEL; CLASSIFICATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; EMBASE; GENE; GENETICS; HEART MUSCLE ISCHEMIA; HEREDITY; HUMAN; INTRON; MEDLINE; META ANALYSIS; PATIENT SELECTION; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; RESEARCH SUBJECT; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; STROKE; SYSTEMATIC REVIEW; WEB BROWSER;

APOLIPOPROTEINS E; BLOOD VESSELS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 56749177589     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000177939     Document Type: Article

References (49)

1. Casas JP, Hingorani AD, Bautista LE, Sharma P: Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652-1661.
2. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P: Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PloS Med 2007;4:e131.
3. Joutel A, Corpechot C, Ducros A, et al: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.
4. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:710-748.
5. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
6. Catto A, Carter AM, Barrett JH, et al: Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996;27:435-440.
7. Dikmen M, Ozbabalik D, Gunes HV, et al: Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 2006;113:307-314.
8. Doi Y, Yoshinari M, Yoshizumi H, et al: Polymorphism of the angiotensin-converting enzyme gene in patients with thrombotic brain infarction. Atherosclerosis 1997;132:145-150.
9. Lin JJ, Yueh KC, Lin GY, et al: Lack of association between angiotensin I-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese. J Formos Med Assoc 2000;99:895-901.
10. Markus HS, Barley J, Lunt R, et al: Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;26:1329-1333.
11. Ohkubo R, Nakagawa M, Ikeda K, et al: Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders. J Neurol Sci 2002;198:31-35.
12. Pera J, Slowik A, Dziedzic T, et al: ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand 2006;114:320-322.
13. Slowik A, Turaj W, Dziedzic T, et al: DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 2004;63:359-361.
14. Szolnoki Z, Somogyvari F, Kondacs A, et al: Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002;249:1391-1397.
15. Tuncer N, Tuglular S, Kilic G, et al: Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Clin Neurosci 2006;13:224-227.
16. Ueda S, Weir CJ, Inglis GC, et al: Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens 1995;13:1597-1601.
17. Alluri RV, Mohan V, Komandur S, et al: MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital-based study. Eur J Neurol 2005;12:40-44.
18. Markus HS, Ali N, Swaminathan R, et al: A common polymorphism in the methylene-tetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 1997;28:1739-1743.
19. Salooja N, Catto A, Carter A, et al: Methylene tetrahydrofolate reductase C677T genotype and stroke. Clin Lab Haematol 1998;20:357-361.
20. Li Z, Sun L, Zhang H, et al: Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylene-tetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 2003;34:2085-2090.
21. Choi BO, Kim NK, Kim SH, et al: Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thrombosis Research 2003;111:39-44.
22. Yeh PS, Lin HJ, Li YH, et al: Prognosis of young ischemic stroke in Taiwan: impact of prothrombotic genetic polymorphisms. Thromb Haemost 2004;92:583-589.
23. Catto AJ, Carter AM, Stickland M, et al: Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 1997;77:730-734.
24. Jood K, Ladenvall P, Tjarnlund-Wolf A, et al: Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005;36:2077-2081.
25. Kokubo Y, Chowdhury AH, Date C, et al: Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000;31:1299-1306.
26. Catto AJ, McCormack LJ, Mansfield MW, et al: Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000;101:399-404.
27. Cerrato P, Baima C, Grasso M, et al: Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort. Cerebrovasc Dis 2005;20:264-269.
28. Gao X, Yang H, ZhiPing T: Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett 2006;398:172-177.
29. Kessler C, Spitzer C, Stauske D, et al: The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997;17:2880-2884.
30. Slowik A, Iskra T, Turaj W, et al: LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease. J Neurol Sci 2003;214:11-16.
31. Wen HM, Baum L, Cheung WS, et al: Apolipoprotein E ε4 allele is associated with the volume of white matter changes in patients with lacunar infarcts. Eur J Neurol 2006;13:1216-1220.
32. Hassan A, Gormley K, O'Sullivan M, et al: Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004;35:654-659.
33. Yahashi Y, Kario K, Shimada K, et al: The 27-bp repeat polymorphism in intron 4 of the endothelial cell nitric oxide synthase gene and ischemic stroke in a Japanese population. Blood Coagul Fibrinolysis 1998;9:405-409.
34. Meschia JF: Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research. Stroke 2002;33:2770-2774.
35. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD: Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 2005;365:224-232.
36. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678.
37. Matarin M, Brown WM, Scholz S, et al: A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007;6:414-420.
38. Wang T, Sharma SD, Fox N, Rossor M, Brown MJ, Sharma P: Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients. J Neurol Neurosurg Psychiatry 2000;69:652-654.
39. Dong Y, Hassan A, Zhang Z, Huber D, Dalageorgou C, Markus HS: Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke 2003;34:203-205.
40. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS: Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003;34:1364-1369.
41. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens 1994;8:633-634.
42. Morishita R, Gibbons GH, Ellison KE, et al: Evidence for direct local angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-984.
43. Lammie GA: Pathology of lacunar infarction; in Donnan GA, Norrving B, Bamford J, Bogousslavsky J (eds): Subcortical Stroke. New York, Oxford University Press, 2002.
44. Butler R, Morris AD, Burchell B, et al: DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-1168.
45. Sudlow C, Martinez Gonzalez NA, Kim J, et al: Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5,961 cases and 17,965 controls. Stroke 2006;37:364-370.
46. Adams HP Jr, Davis PH, Leira EC, et al: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-131.
47. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
48. Hassan A, Lansbury A, Catto AJ, et al: Angiotensin-converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry 2002;72:343-346.
49. Hassan A, Hunt BJ, O'Sullivan M, et al: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-432.